Exogenic superinfection - main risk of developing TB

K. I. Aksenova, T. M. Aleksandrova (Moscow, Stavropol, Russian Federation)

Source: Annual Congress 2005 - Epidemiology of tuberculosis and surveillance of resistances
Session: Epidemiology of tuberculosis and surveillance of resistances
Session type: Thematic Poster Session
Number: 1261
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. I. Aksenova, T. M. Aleksandrova (Moscow, Stavropol, Russian Federation). Exogenic superinfection - main risk of developing TB. Eur Respir J 2005; 26: Suppl. 49, 1261

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Smoking is a risk factor for TB infection, but is it an additional mortality risk?
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011

Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Risk of developing active TB in children with latent TB infection
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016



Is smoking a major risk factor for COVID-19 infection and severe disease?
Source: Virtual Congress 2020 – Smoking, nicotine and COVID-19 myths and facts. What is the evidence?
Year: 2020


Advancing global programmatic management of latent tuberculosis infection for at risk populations
Source: Eur Respir J 2016; 47:1327-1330
Year: 2016


Risk factors for fatal tuberculosis among immunocompetent patients.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017


Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey
Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017
Year: 2018



The problem of early mortality in pneumococcal pneumonia: a study of risk factors
Source: Eur Respir J 2015; 46: 561-564
Year: 2015


The results of the TB control during of it epidemic in Ukraine on the base of the TB incidence in risk groups studying
Source: Eur Respir J 2003; 22: Suppl. 45, 518s
Year: 2003

High risk of tuberculosis in health care workers in Romania
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006


HIV and multidrug-resistant tuberculosis: overlapping risk factors
Source: Eur Respir J 2015; 45: 567-569
Year: 2015


Tuberculosis in children - risk factors
Source: Eur Respir J 2005; 26: Suppl. 49, 425s
Year: 2005

The risk of tuberculosis in HIV infected in the 12 years of observation
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013


The burden of childhood and adult tuberculosis, including MDR and TDR TB
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014

The influence of the epidemic risk factor on advanced processes in adolescents with newly-detected pulmonary TB
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


A prediction rule to stratify mortality risk of patients with pulmonary tuberculosis
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016